1st Circ. Refuses To Rehear Dispute Over Visudyne

Law360 (February 24, 2009, 12:00 AM EST) -- A federal appeals court has refused to rehear an appeal of a ruling holding QLT Inc. liable for unfair trade practices and unjust enrichment in a patent ownership dispute with a Harvard Medical School affiliate over the eye treatment Visudyne.

The U.S. Court of Appeals for the First Circuit on Monday denied a petition for a panel rehearing or rehearing en banc, upholding its January decision in favor of Massachusetts Eye and Ear Infirmary, a teaching hospital of Harvard Medical School.

The Jan. 12 decision affirmed...
To view the full article, register now.